ArticleTranslational cancer research2020
Imaging features of intrahepatic bile duct adenoma in MRI.
Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Magnetic resonance imaging features of intrahepatic bile duct adenoma: a 10-year retrospective study.BMC medical imaging · 2025Article
- Magnetic Resonance Imaging Findings of an Intrahepatic Bile Duct Adenoma: A Case Report.Cureus · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntrahepatic bile duct adenoma (BDA) is a rare benign epithelial hepatic tumor, and is very easy to miss or misdiagnose. This study was to investigate the magnetic resonance imaging (MRI) findings of intrahepatic BDA and to improve the imaging understanding of the disease.
methodsThe clinical and MRI imaging data of 25 cases of intrahepatic BDA confirmed by operation and pathology were analyzed retrospectively from the aspects of tumor location, size and shape, signal characteristics and enhancement mode.
resultsAmong the 25 patients, 24 cases (96%) were single lesions, only 1 case had multiple lesions (3 lesions), a total of 27 lesions. Twelve lesions were located in the left lobe of the liver, 15 lesions were located in the right lobe of the liver, and the lesions were located under or near the hepatic capsule. The lesions were round and the size was 4 to 20 mm, with an average of 10.2 mm. In T1 weighted image (T1WI) sequence, all lesions were low or slightly low signal. In T2 weighted image (T2WI) sequence, 20 lesions were high or slightly high signal (74.1%), 4 were central equal signal peripheral ring high signal, and 3 were equal signal. In diffusion-weighted imaging (DWI) sequence, 23 lesions were high or slightly high signals (85.2%), and 4 were ring high signals. Nineteen lesions (70.4%) showed marked enhancement in the arterial phase, and the portal vein and lag phase continued to strengthen with a slightly higher or equal signal, 6 lesions (22.2%) showed mild or obvious peripheral ring enhancement in the arterial phase, and the portal vein and lag phase continued to strengthen with a slightly higher signal around the circumference and a slightly lower signal at the center. Eight cases were examined by gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI, 7 cases were low signal in hepatobiliary phase, and 1 case was Peripheral low signal.
conclusionsThe MRI findings of intrahepatic BDA have certain characteristics. Careful observation and analysis are helpful to the understanding and diagnosis of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.